Ratings by UBS (Trung Huynh)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 11/7/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2025 | Abbvie | ABBV | Maintain | Neutral (N/A) |
|
Details | ||
| 10/14/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 8/27/2025 | Regeneron Pharma | REGN | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/27/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 8/13/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 8/8/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 8/1/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/11/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/11/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 7/10/2025 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 7/8/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (Buy) |
|
Details | ||
| 7/2/2025 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 6/27/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 6/12/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 6/10/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 6/9/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 6/5/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 6/3/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/29/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 5/19/2025 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 5/9/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 5/2/2025 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 4/30/2025 | Regeneron Pharma | REGN | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/17/2025 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 4/11/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/3/2025 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 4/1/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/24/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 2/21/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 2/5/2025 | Regeneron Pharma | REGN | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/3/2025 | Abbvie | ABBV | Maintain | Neutral (Neutral) |
|
Details | ||
| 1/15/2025 | Regeneron Pharma | REGN | Downgrade | Neutral (Buy) |
690.87 (840.84) |
21.71% | Details | |
| 11/12/2024 | Abbvie | ABBV | Maintain | Neutral (N/A) |
|
Details | ||
| 11/12/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2024 | Abbvie | ABBV | Maintain | Neutral (N/A) |
|
Details | ||
| 10/10/2024 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
4.34 (3.10) |
-28.57% | Details | |
| 10/10/2024 | Kyverna Therapeutics Inc | KYTX | New Coverage | Buy (N/A) |
4.60 (8.87) |
92.83% | Details | |
| 10/9/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2024 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 7/12/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 7/12/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2024 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2024 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2024 | Insmed | INSM | New Coverage | Buy (N/A) |
27.28 (130.66) |
378.96% | Details | |
| 2/7/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 10/27/2023 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 10/20/2023 | Bristol-Myers Squibb Co. | BMY | New Coverage | Neutral (N/A) |
56.85 (53.06) |
-6.67% | Details | |
| 10/20/2023 | Eli Lilly | LLY | New Coverage | Buy (N/A) |
607.24 (1041.51) |
71.52% | Details |
